GILD
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.
Recent news mentioning GILD
- — Rosen Law Firm Encourages Gildan Activewear Inc. Investors to Inquire About Securities Class Action Investigation - GIL
- — Ermenegildo Zegna N.V. Q2 2026 Earnings Call Summary
- — Ermenegildo Zegna H1 Earnings Call Highlights
- — Ermenegildo Zegna’s H1 Operating Profit Boosted by Zegna Brand’s Margins
- — Rosen Law Firm Encourages Gildan Activewear Inc. Investors to Inquire About Securities Class Action Investigation - GIL
- — Rosen Law Firm Encourages Gildan Activewear Inc. Investors to Inquire About Securities Class Action Investigation - GIL
- — Top economists warn of wealth inequality in U.S. surpassing Gilded Age
- — GIL Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Gildan Activewear Inc.
- — Can MacroGenics (MGNX) Turn Gilead Sciences (GILD)’s $10M Milestone Into a Major Pipeline Catalyst?
- — Rosen Law Firm Encourages Gildan Activewear Inc. Investors to Inquire About Securities Class Action Investigation - GIL
- — Could Merck & Co., Inc. (MRK) and Gilead Sciences, Inc. (GILD)’s Partnership Create the Next Big Pharma Growth Engine
- — Rosen Law Firm Encourages Gildan Activewear Inc. Investors to Inquire About Securities Class Action Investigation - GIL